All News

Autologous

Shining the Spotlight on Texas Biotech Companies
30 October 2024
Shining the Spotlight on Texas Biotech Companies
ATW 2025 is taking place
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
29 November 2023
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
FDA investigates T cell malignancy
Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization
24 August 2023
Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization
Cellares has secured $255 million
FDA Approves Orphan Drug Designation for NXC-201 as a Treatment for Multiple Myeloma
23 August 2023
FDA Approves Orphan Drug Designation for NXC-201 as a Treatment for Multiple Myeloma
The FDA has granted Orphan
POPULAR NEWS ITEMS
Image
10 January 2025

Must-See Sessions at Advanced Therapies Week 2025: Ry Leahy, Head of Content, Phacilitate

Image
26 November 2024

ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies

Image
19 November 2024

Texas Cell and Gene Manufacturing Landscape

FDA Clears Aspen Neuroscience’s Cell Therapy IND Application for Parkinson’s Disease
23 August 2023
FDA Clears Aspen Neuroscience’s Cell Therapy IND Application for Parkinson’s Disease
The FDA has cleared Aspen
Kyverna’s Series B Financing Round Extends to $145M
3 August 2023
Kyverna’s Series B Financing Round Extends to $145M
Kyverna Therapeutics has oversubscribed its
Mustang Bio Announces Amendment and Closing of Manufacturing Partnership with uBriGene (Boston)
1 August 2023
Mustang Bio Announces Amendment and Closing of Manufacturing Partnership with uBriGene (Boston)
Mustang Bio has announced the
Iovance Biotherapeutics Announces Positive Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer
12 July 2023
Iovance Biotherapeutics Announces Positive Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer
Iovance announced its positive regulatory
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Must-See Sessions at Advanced Therapies Week 2025: Ry Leahy, Head of Content, Phacilitate

Image

ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies

Image

Texas Cell and Gene Manufacturing Landscape